Literature DB >> 7918674

Expression of annexin VI in A431 carcinoma cells suppresses proliferation: a possible role for annexin VI in cell growth regulation.

J Theobald1, P D Smith, S M Jacob, S E Moss.   

Abstract

Human A431 cells exhibit many characteristics typical of transformed cells, such as lack of contact inhibition and reduced growth factor requirement. We have used these cells as a model for the study of annexin VI function, since they do not normally express this protein. In this study we isolated two stably transfected clones, both of which were found to express annexin VI at physiological levels, and examined various growth parameters associated with the transformed phenotype. In low serum, normal A431 cells had doubling times similar to those observed in high serum. However, although the annexin VI transfectants grew only slightly more slowly than controls in high serum, their doubling time was significantly increased in low serum. Moreover, in low serum the annexin VI transfectants stopped proliferating after reaching confluence, indicating contact inhibition. Fluorescence activated cell sorting analysis revealed that the annexin VI+ cells were growth arrested in the G1 phase of the cell cycle when cultured in low serum, whereas annexin VI- clones exhibited the same proportion of mitotic cells in both low and high serum. Thus, expression of annexin VI in a heterologous cell line has a moderating influence on cell proliferation suggesting a possible role for annexin VI in cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918674     DOI: 10.1016/0167-4889(94)90099-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions.

Authors:  Amos M Sakwe; Rainelli Koumangoye; Bobby Guillory; Josiah Ochieng
Journal:  Exp Cell Res       Date:  2010-12-24       Impact factor: 3.905

2.  Functional analysis of the human annexin I and VI gene promoters.

Authors:  S R Donnelly; S E Moss
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

3.  Cell cycle and post-transcriptional regulation of annexin expression in IMR-90 human fibroblasts.

Authors:  P Raynal; H B Pollard; M Srivastava
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 4.  Functional and genetic analysis of annexin VI.

Authors:  H C Edwards; S E Moss
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

5.  Role of annexin A6 in cancer.

Authors:  Houbao Qi; Shuqing Liu; Chunmei Guo; Jiasheng Wang; Frederick T Greenaway; Ming-Zhong Sun
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

6.  Immunological development and cardiovascular function are normal in annexin VI null mutant mice.

Authors:  T E Hawkins; J Roes; D Rees; J Monkhouse; S E Moss
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy.

Authors:  S W Jans; Y F de Jong; C P Reutelingsperger; G J van der Vusse; M van Bilsen
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

8.  Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism.

Authors:  C Giulivi
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 9.  Biophysical aspects of biomineralization.

Authors:  Maytê Bolean; Ana M S Simão; Marina B Barioni; Bruno Z Favarin; Heitor G Sebinelli; Ekeveliny A Veschi; Tatiane A B Janku; Massimo Bottini; Marc F Hoylaerts; Rosangela Itri; José L Millán; Pietro Ciancaglini
Journal:  Biophys Rev       Date:  2017-08-29

10.  Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex.

Authors:  Laia Cubells; Sandra Vilà de Muga; Francesc Tebar; Peta Wood; Rachael Evans; Mercedes Ingelmo-Torres; Maria Calvo; Katharina Gaus; Albert Pol; Thomas Grewal; Carlos Enrich
Journal:  Traffic       Date:  2007-09-06       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.